Relationship of gene expression and chromosomal abnormalities in colorectal cancer - PubMed (original) (raw)
. 2006 Feb 15;66(4):2129-37.
doi: 10.1158/0008-5472.CAN-05-2569.
Manny Bacolod, Zachariah Selvanayagam, Ilan Tsafrir, Jinru Shia, Zhaoshi Zeng, Hao Liu, Curtis Krier, Robert F Stengel, Francis Barany, William L Gerald, Philip B Paty, Eytan Domany, Daniel A Notterman
Affiliations
- PMID: 16489013
- DOI: 10.1158/0008-5472.CAN-05-2569
Relationship of gene expression and chromosomal abnormalities in colorectal cancer
Dafna Tsafrir et al. Cancer Res. 2006.
Abstract
Several studies have verified the existence of multiple chromosomal abnormalities in colon cancer. However, the relationships between DNA copy number and gene expression have not been adequately explored nor globally monitored during the progression of the disease. In this work, three types of array-generated data (expression, single nucleotide polymorphism, and comparative genomic hybridization) were collected from a large set of colon cancer patients at various stages of the disease. Probes were annotated to specific chromosomal locations and coordinated alterations in DNA copy number and transcription levels were revealed at specific positions. We show that across many large regions of the genome, changes in expression level are correlated with alterations in DNA content. Often, large chromosomal segments, containing multiple genes, are transcriptionally affected in a coordinated way, and we show that the underlying mechanism is a corresponding change in DNA content. This implies that whereas specific chromosomal abnormalities may arise stochastically, the associated changes in expression of some or all of the affected genes are responsible for selecting cells bearing these abnormalities for clonal expansion. Indeed, particular chromosomal regions are frequently gained and overexpressed (e.g., 7p, 8q, 13q, and 20q) or lost and underexpressed (e.g., 1p, 4, 5q, 8p, 14q, 15q, and 18) in primary colon tumors, making it likely that these changes favor tumorigenicity. Furthermore, we show that these aberrations are absent in normal colon mucosa, appear in benign adenomas (albeit only in a small fraction of the samples), become more frequent as disease advances, and are found in the majority of metastatic samples.
Similar articles
- Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.
Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MA, van Criekinge W, Thas O, Matthäi A, Cuesta MA, Terhaar Sive Droste JS, Craanen M, Schröck E, Ylstra B, Meijer GA. Carvalho B, et al. Gut. 2009 Jan;58(1):79-89. doi: 10.1136/gut.2007.143065. Epub 2008 Oct 1. Gut. 2009. PMID: 18829976 - Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.
Zarzour P, Boelen L, Luciani F, Beck D, Sakthianandeswaren A, Mouradov D, Sieber OM, Hawkins NJ, Hesson LB, Ward RL, Wong JW. Zarzour P, et al. Genes Chromosomes Cancer. 2015 May;54(5):303-14. doi: 10.1002/gcc.22243. Epub 2015 Feb 27. Genes Chromosomes Cancer. 2015. PMID: 25726927 - Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.
Jiang JK, Chen YJ, Lin CH, Yu IT, Lin JK. Jiang JK, et al. Genes Chromosomes Cancer. 2005 May;43(1):25-36. doi: 10.1002/gcc.20167. Genes Chromosomes Cancer. 2005. PMID: 15723340 - Chromosomal abnormalities: detection and implications for cancer development.
Dos Santos NR, Van Kessel AG. Dos Santos NR, et al. Anticancer Res. 1999 Nov-Dec;19(6A):4697-714. Anticancer Res. 1999. PMID: 10697586 Review. - Genomics and proteomics approaches for biomarker discovery in sporadic colorectal cancer with metastasis.
González-González M, Garcia JG, Montero JA, Fernandez LM, Bengoechea O, Muñez OB, Orfao A, Sayagues JM, Fuentes M. González-González M, et al. Cancer Genomics Proteomics. 2013 Jan-Feb;10(1):19-25. Cancer Genomics Proteomics. 2013. PMID: 23382583 Review.
Cited by
- Gain-Type Aneuploidies Influence the Burden of Selective Long Non-Coding Transcripts in Colorectal Cancer.
Scuderi C, Di Bella V, Privitera AP, Giustolisi FM, Barresi V, Condorelli DF. Scuderi C, et al. Int J Mol Sci. 2024 May 19;25(10):5538. doi: 10.3390/ijms25105538. Int J Mol Sci. 2024. PMID: 38791575 Free PMC article. - Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.
Krivec N, Ghosh MS, Spits C. Krivec N, et al. Stem Cell Reports. 2024 Jan 9;19(1):11-27. doi: 10.1016/j.stemcr.2023.11.013. Epub 2023 Dec 28. Stem Cell Reports. 2024. PMID: 38157850 Free PMC article. Review. - Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.
Bravo-Estupiñan DM, Aguilar-Guerrero K, Quirós S, Acón MS, Marín-Müller C, Ibáñez-Hernández M, Mora-Rodríguez RA. Bravo-Estupiñan DM, et al. Cancer Med. 2023 Dec;12(24):22130-22155. doi: 10.1002/cam4.6719. Epub 2023 Nov 21. Cancer Med. 2023. PMID: 37987212 Free PMC article. Review. - Integrated bioinformatics analysis reveals the function and prognostic value of OSBPL3 in hepatocellular carcinoma.
Su Y, Xue C, Gu X, Sun Y, Zhang R, Li L. Su Y, et al. Heliyon. 2023 Jun 12;9(6):e17223. doi: 10.1016/j.heliyon.2023.e17223. eCollection 2023 Jun. Heliyon. 2023. PMID: 37389070 Free PMC article. - Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas.
Tang Z, Liu L, Borlak J. Tang Z, et al. Clin Epigenetics. 2023 May 19;15(1):89. doi: 10.1186/s13148-023-01500-1. Clin Epigenetics. 2023. PMID: 37208732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical